ranimustine has been researched along with Nausea in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ashizawa, M; Fujiwara, S; Hatano, K; Ito, S; Kako, S; Kanda, Y; Kawasaki, Y; Mashima, K; Minakata, D; Muroi, K; Nakano, H; Oh, I; Ohmine, K; Okazuka, K; Sato, K; Sugimoto, M; Suzuki, T; Umino, K; Yamamoto, C; Yamasaki, R | 1 |
Fujita, S; Fujitake, H; Hirata, M; Horiuchi, A; Kanamaru, A; Kawagoe, H; Kitani, T; Masaoka, T; Nagai, K; Ohkubo, A; Okamoto, Y; Takubo, T; Taniguchi, N; Tsubaki, K; Tsubakio, T; Yasunaga, K; Yonezawa, T | 1 |
Kagawa, T; Konishi, S; Moritake, K; Nagai, H; Nagao, S; Yamasaki, T | 1 |
Fujiwara, Y; Hirota, Y; Kobayashi, M; Kobayashi, T; Mitomo, Y; Ohno, R; Shirakawa, S; Tanaka, I; Yamada, H; Yamamoto, M | 1 |
4 other study(ies) available for ranimustine and Nausea
Article | Year |
---|---|
Retrospective evaluation of the MEAM regimen as a conditioning regimen before autologous peripheral blood stem cell transplantation for lymphoma in two centers with different dosing schedules of melphalan.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Disease-Free Survival; Dose-Response Relationship, Drug; Etoposide; Febrile Neutropenia; Female; Humans; Lymphoma; Male; Melphalan; Middle Aged; Nausea; Nitrosourea Compounds; Peripheral Blood Stem Cell Transplantation; Retrospective Studies; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome; Young Adult | 2016 |
[Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
Topics: Administration, Oral; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Leukopenia; Nausea; Neoplasms; Nitrosourea Compounds; Tablets; Thrombocytopenia | 1983 |
[The efficacy of granisetron as a prophylactic anti-emetic agent used in conjunction with MCNU and VP16 chemotherapeutic regimens in the management of a pediatric case of hypothalamic anaplastic astrocytoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Etoposide; Glioblastoma; Granisetron; Humans; Hypothalamic Neoplasms; Interferon-beta; Male; Nausea; Nitrosourea Compounds; Vomiting | 1995 |
[Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
Topics: Administration, Oral; Antineoplastic Agents; Drug Administration Schedule; Drug Evaluation; Humans; Myeloproliferative Disorders; Nausea; Nitrosourea Compounds; Tablets; Vomiting | 1987 |